相关实验视频

Updated: Jul 2, 2025

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

"高血糖记忆":对实验推断的观察证据

Mohsen Ahmadi¹, Soudeh Ghafouri-Fard¹, Parisa Najari-Hanjani²

¹Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Current diabetes reviews

|February 19, 2024

概括

早期糖尿病控制通过高血糖记忆对长期健康产生影响. 这种现象,即暂时高血糖 (高血糖) 影响未来的并发症,是由分子机制解释的.

科学领域:

内分泌学和新陈代谢学
分子生物学分子生物学
糖尿病学糖尿病学

背景情况:

流行病学研究将高血糖持续时间和水平与糖尿病并发症联系起来.
仅仅是血糖概况并不能完全解释并发症的严重程度或存在.
遗传因素和高血糖记忆被认为是关键影响因素.

研究的目的:

审查支持高血糖记忆概念的证据.
探索超血糖记忆背后的分子机制.
为早期血糖控制的长期影响提供分子基础.

主要方法:

流行病学研究和临床试验的审查 (DCCT/EDIC,UKPDS).
对涉及高血糖记忆的拟议分子途径的分析.
对高血糖记忆的分子证明的证据综合.

主要成果:

早期的血糖控制对糖尿病并发症有持久的保护性或有害影响.
过渡性高血糖症可以诱导持续的细胞反应.
几种分子机制与高血糖记忆有关.

结论:

高血糖记忆是糖尿病并发症病理生物学的一个重要因素.
像AGE,ROS,PKC,表观遗传变化和miRNAs这样的分子现象调解高糖记忆.
了解这些机制对于管理糖尿病的长期结果至关重要.

关键词:

糖尿病糖尿病糖尿病先进的糖化最终产品.表观遗传学是指表观遗传学.过高血糖. 过高血糖. 过高血糖. 过高血糖.过高血糖记忆过高血糖记忆遗留效应遗留效应遗留效应

更多相关视频

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

相关概念视频

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...